Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. This activity reviews the indications, mechanism of action, contraindications, adverse effects, and other key factors (e.g., off-label uses, monitoring) pertinent for the healthcare team members.

**Objectives:**
- Describe the mechanism of action of rituximab.
- Review the indications for rituximab therapy.
- Identify the most common adverse events associated with rituximab therapy.
- Outline the requisite monitoring during rituximab therapy.